Once again, it’s debunking time.
The New York Post headline — “Bombshell cannabis study reveals hidden risks of medical pot” — is a textbook example of how cannabis continues to be treated differently from almost every other therapeutic substance in mainstream media. The problem is not the study itself, but what this media outlet does with it.
The UCLA-led review published in JAMA does not conclude that medical cannabis is dangerous, fraudulent, or a failed therapy. What it actually concludes is something far more modest and far more common in medicine: that the evidence base is uneven, incomplete, and in need of better research.
That is something cannabis advocates have been saying for decades, and it is an argument for expanding research, not restricting access.
What the Study Actually Says (and What It Doesn’t)
Dr. Michael Hsu, the study’s lead author, states plainly: “Further research is crucial to better understand the potential benefits and risks of medical cannabis.”
The review examined more than 2,500 studies published between 2010 and 2025, narrowing its focus to roughly 120 higher-quality papers. Its conclusions are careful and measured.
The authors found strong evidence for FDA-approved cannabinoid medicines in limited contexts such as chemotherapy-induced nausea, HIV-related appetite loss, and rare pediatric epilepsies. For other common uses, including chronic pain, anxiety, and insomnia, the evidence is mixed or insufficient, not disproven. The review also notes potential risks associated with high-potency, frequent use, particularly among adolescents or people with certain vulnerabilities.
Crucially, the authors acknowledge that the review is not systematic, lacks formal bias assessment, and relies in part on observational studies that are vulnerable to confounding factors.
Most importantly, the paper calls for more rigorous research, not restriction, prohibition, or panic.
How the Media Distorts That Message
The New York Post follows a familiar pattern, treating scientific uncertainty as …
Read More
Author: Rolando García / High Times
